Healthcare Services

Vaccine Contract Manufacturing Market Developments and Growth Opportunities Across 2026–2030

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Vaccine Contract Manufacturing Market Projected To Become By 2030 Based On Its 2026 Valuation?

The vaccine contract manufacturing market has experienced robust expansion in recent years. It is forecast to rise from $3.88 billion in 2025 to $4.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The past growth can be attributed to the broadening of global immunization initiatives, the escalating intricacy of vaccine production methods, a greater dependence on specialized contract manufacturers, the proliferation of public-private vaccine partnerships, and the establishment of extensive vaccine production facilities.

The vaccine contract manufacturing market size is projected to experience substantial expansion over the upcoming years. By 2030, it is anticipated to reach $6.46 billion, exhibiting a compound annual growth rate (CAGR) of 10.9%. This anticipated expansion throughout the projected timeframe stems from factors such as heightened demand for swift vaccine scale-up, increased capital allocation towards mRNA and innovative next-generation vaccines, the broadening of commercial production facilities, a stronger emphasis on achieving regional vaccine autonomy, and the integration of cutting-edge bioprocess technologies. Key developments expected during this period involve a surge in the outsourcing of vaccine manufacturing, an escalating need for adaptable production capabilities, the enhancement of fill-finish service offerings, a sharpened focus on manufacturing processes that comply with regulations, and a greater embrace of single-use bioprocessing systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp

Which Market Drivers Are Supporting The Expansion Of The Vaccine Contract Manufacturing Market?

The global increase in infectious diseases is projected to stimulate the expansion of the vaccine contract manufacturing market. Infectious diseases are conditions caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. During outbreaks of these diseases, including influenza, measles, or emerging viruses, there is a pressing requirement for vaccines to prevent further transmission, a need that contract manufacturers can address by quickly scaling up production. For instance, in October 2024, data from the World Health Organization, an international public health organization located in Switzerland, indicated that around 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from approximately 7.5 million in 2022, establishing tuberculosis as the leading infectious disease fatality. Therefore, the escalating prevalence of infectious diseases worldwide is a key driver for the growth of the vaccine contract manufacturing market.

What Segment Groups Are Identified Within The Vaccine Contract Manufacturing Market?

The vaccine contract manufacturing market covered in this report is segmented –

1) By Service Type: Fill-Finish, Bulk Product

2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines

3) By Process: Downstream, Upstream

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By End-Use: Human Use, Veterinary

Subsegments:

1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling

2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation

What Trends Are Affecting The Expansion Of The Vaccine Contract Manufacturing Market?

Leading firms within the vaccine contract manufacturing market are prioritizing the establishment of new production sites for vaccine contract manufacturing as a strategy to maintain their competitive standing. A production site opening in vaccine contract manufacturing signifies the creation of a specialized facility dedicated to the contractual manufacturing and production of vaccines. An illustrative example occurred in September 2023 when WuXi Vaccines, a China-based contract development and manufacturing organization (CDMO) specializing in vaccine discovery and production, inaugurated its initial dedicated vaccine CDMO site in Suzhou, China. This expansion represents a significant achievement for the company, enhancing its capacities for both drug substance and drug product manufacturing. WuXi Vaccines now provides a full spectrum of services for various vaccines, encompassing process development, drug product development, and the manufacturing of clinical-scale drug substances (DS) along with small-to-medium sterile drug products (DP). The newly independent site boosts WuXi Vaccines’ ability to contribute to vaccine development and manufacturing, thereby playing a crucial part in advancing worldwide healthcare solutions.

Which Companies Hold Significant Positions In The Vaccine Contract Manufacturing Market?

Major companies operating in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Bio Farma, Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L

Read the full vaccine contract manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report

How Is The Vaccine Contract Manufacturing Market Distributed Across Key Geographic Regions?

North America was the largest region in the vaccine contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vaccine Contract Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12216&type=smp

Browse Through More Reports Similar to the Global Vaccine Contract Manufacturing Market 2026, By The Business Research Company

Antibody Contract Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report

Biopharmaceuticals Contract Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795